GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

BIT:1GILD • US3755581036

128.32 EUR
+7.58 (+6.28%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall 1GILD gets a fundamental rating of 6 out of 10. We evaluated 1GILD against 78 industry peers in the Biotechnology industry. 1GILD has an excellent profitability rating, but there are some minor concerns on its financial health. 1GILD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • 1GILD had positive earnings in the past year.
  • 1GILD had a positive operating cash flow in the past year.
  • 1GILD had positive earnings in 4 of the past 5 years.
  • 1GILD had a positive operating cash flow in 4 of the past 5 years.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • The Return On Assets of 1GILD (13.86%) is better than 87.65% of its industry peers.
  • With an excellent Return On Equity value of 37.80%, 1GILD belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 18.54%, 1GILD belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1GILD is above the industry average of 11.39%.
  • The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • 1GILD has a Profit Margin of 27.88%. This is amongst the best in the industry. 1GILD outperforms 85.19% of its industry peers.
  • 1GILD's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1GILD (38.96%) is better than 96.30% of its industry peers.
  • 1GILD's Operating Margin has improved in the last couple of years.
  • 1GILD has a Gross Margin of 78.72%. This is in the better half of the industry: 1GILD outperforms 66.67% of its industry peers.
  • 1GILD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1GILD is still creating some value.
  • 1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • 1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.57
WACC11.79%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that 1GILD should not have too much problems paying its short term obligations.
  • 1GILD has a Current ratio of 1.53. This is comparable to the rest of the industry: 1GILD outperforms 40.74% of its industry peers.
  • A Quick Ratio of 1.17 indicates that 1GILD should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.17, 1GILD is not doing good in the industry: 61.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • 1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 2.83% on average over the past years.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • 1GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
  • Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.68, the valuation of 1GILD can be described as rather expensive.
  • Based on the Price/Earnings ratio, 1GILD is valued cheaper than 88.89% of the companies in the same industry.
  • 1GILD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.09.
  • The Price/Forward Earnings ratio is 17.07, which indicates a rather expensive current valuation of 1GILD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 92.59% of the companies listed in the same industry.
  • 1GILD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.68
Fwd PE 17.07
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 85.19% of the companies in the same industry.
  • 1GILD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1GILD is cheaper than 91.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.84
EV/EBITDA 12.73
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1GILD does not grow enough to justify the current Price/Earnings ratio.
  • 1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.98
PEG (5Y)6.61
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • 1GILD has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.47, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 96.30% of the companies listed in the same industry.
  • 1GILD's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • 1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

BIT:1GILD (2/6/2026, 7:00:00 PM)

128.32

+7.58 (+6.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap159.20B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.62
Price Target118.53 (-7.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.65
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)7.54%
PT rev (3m)5.6%
EPS NQ rev (1m)-2.7%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 18.68
Fwd PE 17.07
P/S 6.49
P/FCF 19.84
P/OCF 19.54
P/B 8.8
P/tB N/A
EV/EBITDA 12.73
EPS(TTM)6.87
EY5.35%
EPS(NY)7.52
Fwd EY5.86%
FCF(TTM)6.47
FCFY5.04%
OCF(TTM)6.57
OCFY5.12%
SpS19.76
BVpS14.58
TBVpS-3.28
PEG (NY)1.98
PEG (5Y)6.61
Graham Number47.47
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC11.79%
ROIC/WACC1.57
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status for 1GILD stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 18.68 and the Price/Book (PB) ratio is 8.8.


What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.